Medidata expands executive leadership team
Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Aug 10, 2026
The executive appointments signal Dassault Systèmes — Medidata Solutions's focus on scaling operations and accelerating growth, which may positively influence investor sentiment toward Dassault Systèmes, its parent company. The moves are unlikely to have a significant immediate impact on the broader market but could strengthen Dassault Systèmes — Medidata Solutions's competitive position in the clinical trial technology sector.
Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand and leading provider of clinical trial solutions, announced key appointments to its executive leadership team on August 10, 2026. Lisa Moneymaker, who joined the executive committee in 2024, adds the role of chief operating officer to her current responsibilities as chief strategy officer. Ian Marks joins as chief commercial officer across Dassault Systèmes — Medidata Solutions and Dassault Systèmes' Life Sciences organization, bringing experience from Amazon — Amazon Web Services, Salesforce, GSK plc, Novartis, and Roche. Jeff Ventimiglia has been appointed senior vice president of operations and transformation, and Linda Magrath as senior vice president and head of customer success, services, and support. These moves aim to unify strategy and operations, accelerate growth, and scale clinical trial pipelines for customers. CEO Anthony Costello highlighted the team's potential to deliver success for the business and customers.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard